Comparative Effectiveness and Cost-Effectiveness of Three First-Line EGFR-tyrosine Kinase Inhibitors: Analysis of Real-World Data in a Tertiary Hospital in Taiwan

PLoS ONE - United States
doi 10.1371/journal.pone.0231413
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cn8 - Cost-Effectiveness Analysis of Oral Cancer Screening in Taiwan: A Real World Data Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated With First-Line Tyrosine Kinase Inhibitors

Clinical Cancer Research
Cancer ResearchOncology
2016English

Ce4 - Cost-Effectiveness Analysis of First-Line Osimertinib in Patients With Egfr Mutation-Positive Non-Small Cell Lung Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Comparative Effectiveness Analysis of the Implementation of Surgical Safety Checklists in a Tertiary Care Hospital

JAMA Surgery
Surgery
2016English

P1.01-39 Cost-Effectiveness of Crizotinib Versus Chemotherapy as First-Line Treatment of ALK Positive Advanced NSCLC -- A Real World Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effectiveness and Cost-Effectiveness of Imatinib for First-Line Treatment of Chronic Myeloid Leukaemia in Chronic Phase: A Systematic Review and Economic Analysis

Health Technology Assessment
MedicineHealth Policy
2004English

Co1 Comparative Effectiveness Analysis of TNF Blockers in Rheumatoid Arthritis (Ra) Patients in a Real-World Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Cost-Effectiveness of Xpert MTB/RIF for Tuberculosis Diagnosis in South Africa: A Real-World Cost Analysis and Economic Evaluation

Indian Journal of Tuberculosis
Infectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy